News

Paul Doyle has taken up the role of Chief Scientific Officer at Concept Life Sciences. The news of his new role coincides with the news that the Concept Life Sciences Group has embarked upon a multi-million pound investment drive, comprising a comprehensive expansion and rebranding programme,

Knowledge based, science led business, Concept Life Sciences, has further strengthened its team with the appointment of Tony Johnson as Group Business Development Executive. Tony, who joined the company on 14th November, is based at the group’s new science hub which is located on the Listerhills Science Park in Bradford.

CXR Biosciences, part of the Concept Life Sciences Group, has been crowned winner of the ‘Science and Technology Business of the Year’ award at The Courier Business Awards for the second year running. The award was presented to the company on Saturday 29th October at an official awards ceremony which was held at The Apex City Quay Hotel in Dundee.

Congratulations to Sir Fraser Stoddart and the other recent chemistry Nobel laureates for their research with molecular machines!
It is always good to get some recognition for a job well done and here at Concept Life Sciences one of our chemists can claim a close involvement with the work.

Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group has signed a collaboration agreement with computational chemistry company, Cresset. By partnering with Cresset, Peakdale has further extended its integrated drug discovery offering.

CLIFF ELCOMBE
OBITUARY
Dr Cliff Elcombe was a well-known and accomplished British toxicologist, who spent almost his entire career investigating the mechanisms of toxicity of various industrial chemicals and agrochemicals.  He had an enviable reputation for his knowledge of, and insight into,

Peakdale Molecular, part of the Concept Life Sciences Group, has appointed Dr Paul Bradley as new Head of Chemistry at the company’s Discovery Park site in Sandwich, Kent.
Dr Bradley joins the team with extensive experience across multiple therapeutic areas in drug discovery having previously worked for companies such as Charnwood Molecular Ltd,

It is with great sadness that we learned that our colleague Dr Cliff Elcombe died suddenly last Thursday, 25th August after a short illness.
Cliff was co-founder and Research Director of CXR, and an internationally renowned toxicologist.
Cliff played a huge role in the formation and success of CXR,

In order to further extend its biology and integrated drug discovery offering Peakdale Molecular Limited has added two new members to its team. Christopher Doe, PhD, joins as Head of Biology and Sascha Hartmann has joined the business development team as Business Development Manager – Biology Services.

Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries has signed an agreement to extend its research collaboration with Centauri Therapeutics, a UK based biotechnology company focussed on the discovery and development of novel molecules targeting life threatening diseases.

Our Chief Operating Officer, Dr Paul Doyle has been especially selected to judge entries at the YINI-EDT Business Awards  North West Regional Finals 2016.
The Future Industry Leaders Awards, formerly known as The Contribution to the Business Awards, is a great opportunity for students to showcase their placement projects.

CXR Biosciences, part of the Concept Life Sciences Group, has added in vitro dermal absorption studies to their already comprehensive portfolio of mechanistic toxicology and ADMET services.  This is also the first service that CXR offers to formal Good Laboratory Practice (GLP) standards,

The Concept Life Sciences Group, a group created following the acquisition of Peakdale Molecular Limited, Scientific Analysis Laboratories Limited and Resource & Environmental Consultants Limited, has launched its services in the US. The integrated group, which further expanded following the acquisition of CXR Biosciences and Agenda1 Analytical Services in 2015,

CXR Biosciences, the investigative and exploratory toxicology company, is co-presenting six posters at the upcoming Society of Toxicology meeting in New Orleans on 13th – 17th March.  This innovative research has been performed with several CXR customers including BASF, Adama, Monsanto and the H4R REACH consortium.

An outstanding year for CXR Biosciences was recognised with a triple win at the 2015 Courier Business Awards, including becoming the third winner of the coveted Business of the Year prize at the glittering Courier Business Awards ceremony at the Fairmont St Andrews.

CXR Biosciences, the investigative and exploratory toxicology company, is pleased to announce that it has received French research tax credit approval for years 2015 through to 2017.

UK-based drug discovery services provider Peakdale Molecular (part of the Concept Life Sciences Group) has strengthened its sales and marketing team through the addition of a Head of Sales and Marketing.

Following the previous event in 2012 and 2015, the RSC and SCI are running the 3rd National Retrosynthesis competition with the final being held at RSC HQ, Burlington House on 11th March 2016. The event is open to all UK academic and industrial groups, in previous years having attracted over 150 applicants.